Health Protection Agency Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 Study
Condition: Egg HypersensitivityIntervention: Drug: Administration of Live attenuated influenza vaccine (LAIV)Sponsors: Imperial College London; University Hospitals Southampton NHS Foundation Trust (PRIMARY STUDY SPONSOR); Public Health England (formerly Health Protection Agency)Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2014 Category: Research Source Type: clinical trials
Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 Study
Condition: Egg HypersensitivityIntervention: Drug: Administration of Live attenuated influenza vaccine (LAIV)Sponsors: Imperial College London; University Hospitals Southampton NHS Foundation Trust (PRIMARY STUDY SPONSOR); Public Health England (formerly Health Protection Agency)Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2014 Category: Research Source Type: clinical trials
Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 Study
Condition: Egg HypersensitivityIntervention: Drug: Administration of Live attenuated influenza vaccine (LAIV)Sponsors: Imperial College London; University Hospitals Southampton NHS Foundation Trust (PRIMARY STUDY SPONSOR); Public Health England (formerly Health Protection Agency)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2014 Category: Research Source Type: clinical trials
